Market cap: $18,987,446
Exchange: NAS
Sector: Health Technology
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.
Company Name
Catalyst Biosciences Inc
Average Volume (10 days)
661,014
Average Volume (30 days)
289,043
Moving Average (50 days)
$0.4768
Moving Average (200 days)
$0.355
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
-2.3037
Market Cap
18,987,446
Shares Outstanding
37,974,892
52-Week High Split Adjust Only
0.74
52-Week Low Split Adjust Only
0.1887
Employee Count
35
Beta
0.5728
Next Earnings Date
TTM Dividend Rate Per Share
0
Past 5 days
0.48%
Past 30 days
-0.09%
Past 3 months
0.22%
Past 6 months
1.09%
Past year
-0.15%
Past 2 years
-0.46%
Past 5 years
-0.8%
Max % Change
-0.94%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Catalyst Biosciences Inc | CBIO | n/a | n/a | -1.5 | n/a | n/a |
| Peer Avg | N/A | 2.25 | 4.15 | n/a | 2.25 | 2.23 |
| National Research Corp | NRC | 9.02 | 16.61 | n/a | 9.02 | 8.92 |
| NeuroSense Therapeutics Ltd | NRSN | n/a | n/a | n/a | n/a | n/a |